Citations

Showing 10 of 108094 citations.

Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies
Nielsen, Henrietta M. , Surova, Yulia , Nägga, Katarina , Londos, Elisabet , Minthon, Lennart, Hansson, Oskar , Hansson, Oskar , Hall, Sara , Nilsson, Christer F. , Wennström, Malin

Mayo Clinic

Journal of Alzheimer's Disease | June 4, 2018 | Volume: 40 | Issue: 2 | Pages: 343-350

10.3233/jad-132246 | PMID 24448788 Get It

Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis
Singh, Balwinder , Parsaik, Ajay K. , Mielke, Michelle M. , Erwin, Patricia J., Petersen, Ronald C. , Roberts, Rosebud O., Mielke, Michelle M , Singh, Balwinder , Knopman, David S.

Mayo Clinic

Journal of Alzheimer's Disease | June 4, 2018 | Volume: 39 | Issue: 2 | Pages: 271-282

10.3233/jad-130830 | PMID 24164735 Get It

Endogenous Tau Aggregates in Oligodendrocytes of rTg4510 Mice Induced by Human P301L Tau
Ren, Yan, Lin, Wen-Lang, Ceballos, Carolina, Polydoro, Manuela , Spires‐Jones, Tara L. , Dickson, Dennis W. , Dickson, Dennis W , Sánchez, Laura , Ceballos, Carolina, Hyman, Bradley T. , Sahara, Naruhiko

Mayo Clinic

Journal of Alzheimer's Disease | June 4, 2018 | Volume: 38 | Issue: 3 | Pages: 589-600

10.3233/jad-130986 | PMID 24028867 Get It

TARDBP Mutation Analysis in TDP-43 Proteinopathies and Deciphering the Toxicity of Mutant TDP-43
Rademakers, Rosa , Petrucelli, Leonard , Gendron, Tania F.

Mayo Clinic

Journal of Alzheimer's Disease | June 4, 2018 | Volume: 33 | Issue: s1 | Pages: S35-S45

10.3233/jad-2012-129036 | PMID 22751173 Get It

Characterizing the Preclinical Stages of Alzheimer's Disease and the Prospect of Presymptomatic Intervention
Caselli, Richard J. , Reiman, Eric M.

Mayo Clinic

Journal of Alzheimer's Disease | June 4, 2018 | Volume: 33 | Issue: s1 | Pages: S405-S416

10.3233/jad-2012-129026 | PMID 22695623 Get It

Tau Triage Decisions Mediated by the Chaperone Network
Cook, Casey , Petrucelli, Leonard

Mayo Clinic

Journal of Alzheimer's Disease | June 4, 2018 | Volume: 33 | Issue: s1 | Pages: S145-S151

10.3233/jad-2012-129008 | PMID 22596270 Get It

Supplementation of Nitric Oxide Attenuates AβPP and BACE1 Protein in Cerebral Microcirculation of eNOS-Deficient Mice
Austin, Susan A., Katušić, Zvonimir S. , d’Uscio, Livius V.

Mayo Clinic

Journal of Alzheimer's Disease | June 4, 2018 | Volume: 33 | Issue: 1 | Pages: 29-33

10.3233/jad-2012-121351 | PMID 22886025 Get It

Estimating the Age of the Most Common Italian GRN Mutation: Walking Back to Canossa Times
Benussi, Luisa , Rademakers, Rosa , Rutherford, Nicola J., Wojtas, Aleksandra, Glionna, Michela, Paterlini, Anna , Albertini, Valentina, Bettecken, Thomas, Binetti, Giuliano , Ghidoni, Roberta

Mayo Clinic

Journal of Alzheimer's Disease | June 4, 2018 | Volume: 33 | Issue: 1 | Pages: 69-76

10.3233/jad-2012-121306 | PMID 22890101 Get It

Recognition of Facial Emotional Expression in Amnestic Mild Cognitive Impairment
Varjassyová, Alexandra, Hořínek, Daniel, Andel, Ross , Amlerová, Jana , Laczó, Jan , Sheardová, Kateřina , Magerová, Hana , Holmerová, Iva , Vyhnálek, Martin , Bradáč, Ondřej , Geda, Yonas E. , Hort, Jakub , Geda, Yonas E , Hort, Jakub , Vyhnalek, Martin

Mayo Clinic

Journal of Alzheimer's Disease | June 4, 2018 | Volume: 33 | Issue: 1 | Pages: 273-280

10.3233/jad-2012-120148 | PMID 22954669 Get It

Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma
Thompson, Carrie A. , Yost, Kathleen J. , Allmer, Cristine, Farooq, Umar , Inwards, David J. , Macon, William R. , Link, Brian K. , Rosenthal, Allison , Rosenthal, Allison C, Rosenthal, Allison , Link, Brian K , Farooq, Umar , Maurer, Matthew J. , Habermann, Thomas M. , Cerhan, James R.

Mayo Clinic

Hematological Oncology | June 4, 2018 | Volume: 36 | Issue: 5 | Pages: 749-756

10.1002/hon.2522 | PMID 29862550 Get It

AbstractOur aim was to evaluate whether quality of life (QOL) scores at diagnosis predict survival among patients with aggressive lymphoma. Newly diagnosed lymphoma patients were prospectively enrolled within 9 months of diagnosis in the University of Iowa/Mayo Clinic SPORE and systematically followed for event‐free and overall survival (OS). QOL was measured with the Functional Assessment of Cancer Treatment‐General (FACT‐G), which measures 4 domains: physical, social/family, emotional, and functional well‐being (WB); a single item Linear Analogue Self‐Assessment (LASA) measuring overall QOL; and a spiritual WB LASA. From 9/2002 to 12/2009, 701 patients with aggressive lymphoma who completed baseline QOL questionnaires were enrolled. At a median follow‐up of 71 months (range 6‐128), 316 patients (45%) had an event and 228 patients (33%) died. All baseline QOL measures but emotional WB were significantly associated with OS (all P < 0.04); of which all but LASA spiritual remained significant after adjusting for IPI and NHL subtype. The strongest associations were with total FACT‐G (adjusted HR = 0.86, 95% CI: 0.79‐0.94, P = 0.00062) and functional WB (adjusted HR = 0.88, 95% CI: 0.83‐0.93, P < .0001). QOL LASA was associated with OS (adjusted HR = 0.92, 95% CI: 0.87‐0.97, P = 0.0041). Patients with clinically deficient QOL (overall QOL ≤50) had a median OS of 92 months compared with 121 months for patients with QOL >50 (P = 0.0004). In this large sample of patients with aggressive lymphoma, we found that baseline QOL is independently predictive of OS. QOL should be assessed as a prognostic factor in patients with aggressive lymphoma.